Donate

News

Categories
Sign up to our newsletter

Treatment Updates

Image of entrance sign to PA Hospital
CAR T-cell therapy now available at Princess Alexandra Hospital, Brisbane
published June 3, 2025
Great news for patients in QLD with another hospital accredited to provide CAR T-cell therapy for eligible pat
Read more
Tracking Long-term Effects of Cancer Treatment
published April 28, 2025
Roughly 800 people are diagnosed with Hodgkin Lymphoma each year in Australia, and both adults and children ca
Read more
CLL/SLL, MCL, MZL, WM – BRUKINSA® (Zanubrutinib) updates
published April 7, 2025
The TGA has approved zanubrutinib for more people with lymphoma, and some of these are now PBS listed.
Read more
Image showing car t-cell process from initial collection of T-cells, to being modifies in the lab and then returned to patient
CAR T-cell Therapy – Now available in 2nd line treatment
published April 2, 2025
CAR T-cell therapy is an advanced treatment that helps your immune system fight the lymphoma. It involves coll
Read more
Image of a bi-specific antibody attaching to the CD3 protein on a T-cell and the CD20 on the lymphoma cell
Epcoritamab – New Treatment for DLBCL
published April 2, 2025
Epcoritamab, (brand name EPKINLY®) is a new bispecific antibody treatment. It is now provisionally approved i
Read more
Logo for Juniper biologics
Great news for patients with Mycosis Fungoides
published January 23, 2025
LEDAGA® now PBS listed for patients with limited stage Mycosis Fungoides T-cell lymphoma.
Read more
CAR T-cell Therapy now available in North Queensland
published July 12, 2024
Gilead welcomes the opening of Australia’s first regional CAR T-cell treatment centre at Townsville Hospital
Read more
Your Life Matters
published November 6, 2023
Are you living (or caring for someone) with Chronic Lymphocytic Leukaemia or Small Lymphocytic Leukaemia? A g
Read more
New CAR T Cell Therapy option now available in Australia for some patients with Lymphoma
published August 5, 2021
Eligible patients can now access Yescarta through Royal Brisbane and Women’s Hospital, Brisbane and the Pete
Read more
New treatments available
MabThera (rituximab) Update
published March 30, 2021
IMPORTANT Information for all Lymphoma/ CLL Australian patients receiving MabThera® (rituximab)   From
Read more
New treatments available
Australian lymphoma patients will now have access to a new frontline therapy for CLL*
published November 30, 2020
The combination of VENCLEXTA plus obinutuzumab will be available as a fixed duration therapy for previously un
Read more

Sign up to our Newsletter

Back to top
Sign Up
About Us
Lymphoma
Patients
Get Involved
Lymphoma Australia is the only incorporated charity in Australia dedicated to solely providing education, support, awareness and advocacy initiatives for Australians touched by lymphoma and chronic lymphocytic leukemia (CLL).
Copyright © 2025. Lymphoma Australia
Linkedin Spotify
Contact Us
Cart
Checkout - $0.00
  • 0
  • 1

Contact Lymphoma Australia Today!

Patient Support Hotline

General Enquiries

Please note: Lymphoma Australia staff are only able to reply to emails sent in English language.

For people living in Australia, we can offer a phone translation service. Have your nurse or English speaking relative call us to arrange this.

Newsletter Sign Up

Useful Definitions

  • Refractory: This means the lymphoma does not get better with treatment. The treatment didn’t work as hoped.
  • Relapsed: This means the lymphoma came back after being gone for a while after treatment.
  • 2nd line treatment: This is the second treatment you get if the first one didn’t work (refractory) or if the lymphoma comes back (relapse).
  • 3rd line treatment: This is the third treatment you get if the second one didn’t work or the lymphoma comes back again.
  • Approved: Available in Australia and listed by the Therapeutics Goods Administration (TGA).
  • Funded: Costs are covered for Australian citizens. This means if you have a Medicare card, you shouldn’t have to pay for the treatment.[WO7]

You need healthy T-cells to make CAR T-cells. For this reason, CAR T-cell therapy cannot be used if you have a T-cell lymphoma – yet.

For more information on CAR T-cells and T-cell lymphoma click here. 

Special Note: Although your T-cells are removed from your blood for CAR T-cell therapy, most of our T-cells live outside of our blood – in our lymph nodes, thymus, spleen and other organs.